Beam Therapeutics (BEAM) Short Interest Ratio & Short Volume → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free BEAM Stock Alerts $24.62 +0.83 (+3.49%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Beam Therapeutics Short Interest DataCurrent Short Volume14,020,000 sharesPrevious Short Volume13,170,000 sharesChange Vs. Previous Month+6.45%Dollar Volume Sold Short$297.50 millionShort Interest Ratio / Days to Cover9.3Last Record DateApril 30, 2024Outstanding Shares82,311,000 sharesPercentage of Shares Shorted17.03%Today's Trading Volume1,332,100 sharesAverage Trading Volume1,412,702 sharesToday's Volume Vs. Average94% Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBEAM Short Interest Over TimeBEAM Days to Cover Over TimeBEAM Percentage of Float Shorted Over Time Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here Beam Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202414,020,000 shares $297.50 million +6.5%N/A9.3 $21.22 4/15/202413,170,000 shares $338.47 million -2.1%N/A8.4 $25.70 3/31/202413,450,000 shares $444.39 million -6.1%N/A9.7 $33.04 3/15/202414,320,000 shares $507.07 million +9.2%N/A10.1 $35.41 2/29/202413,110,000 shares $517.71 million -2.4%N/A9.2 $39.49 2/15/202413,430,000 shares $443.46 million +0.3%N/A9.6 $33.02How this is some devastating news (Ad)Check out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables?But I can promise that you’ll see all the details for yourself here. 1/31/202413,390,000 shares $326.72 million +2.0%N/A9.7 $24.40 1/15/202413,130,000 shares $336.13 million -2.7%N/A8.7 $25.60 12/31/202313,490,000 shares $367.20 million +0.1%N/A9.4 $27.22 12/15/202313,480,000 shares $383.10 million +3.7%N/A9.5 $28.42 11/30/202313,000,000 shares $365.04 million -6.0%N/A9.8 $28.08 11/15/202313,830,000 shares $347.82 million -4.3%N/A11.1 $25.15 10/31/202314,450,000 shares $305.47 million -4.3%N/A13.6 $21.14 10/15/202315,100,000 shares $336.13 million +5.2%N/A16.3 $22.26 9/30/202314,350,000 shares $345.12 million +6.2%N/A16.5 $24.05 9/15/202313,510,000 shares $338.43 million +2.9%N/A16.1 $25.05 8/31/202313,130,000 shares $304.35 million +0.5%N/A15.8 $23.18 8/15/202313,060,000 shares $316.97 million +8.8%N/A15.8 $24.27 7/31/202312,000,000 shares $370.44 million -3.7%N/A14.1 $30.87 7/15/202312,460,000 shares $384.52 million -1.4%N/A15.1 $30.86 6/30/202312,630,000 shares $403.28 million +1.5%N/A15.3 $31.93 6/15/202312,450,000 shares $423.30 million -0.5%N/A14.6 $34.00 5/31/202312,510,000 shares $399.07 million -4.9%20.0%13.6 $31.90 5/15/202313,150,000 shares $473.27 million +3.3%21.0%13.4 $35.99 4/30/202312,730,000 shares $390.94 million -1.1%21.4%13.7 $30.71 4/15/202312,870,000 shares $402.44 million -5.4%21.7%13.8 $31.27 3/31/202313,610,000 shares $416.74 million -2.2%22.9%14.6 $30.62 3/15/202313,910,000 shares $488.24 million +11.5%23.5%15.3 $35.10 2/28/202312,480,000 shares $502.20 million +4.4%21.1%14.9 $40.24 2/15/202311,950,000 shares $525.08 million -3.8%20.7%15.2 $43.94 1/31/202312,420,000 shares $539.65 million -4.5%21.5%14.8 $43.45 1/15/202313,010,000 shares $562.55 million +9.0%22.6%15.6 $43.24 12/30/202211,940,000 shares $466.97 million +1.7%20.7%14.3 $39.11 12/15/202211,740,000 shares $496.72 million -5.6%20.4%13.9 $42.31 11/30/202212,440,000 shares $574.60 million -4.4%21.6%14 $46.19 11/15/202213,010,000 shares $639.83 million -0.7%22.6%13.8 $49.18 10/31/202213,100,000 shares $577.19 million +0.2%23.8%12.2 $44.06 10/15/202213,080,000 shares $594.75 million -0.3%23.8%12.2 $45.47 9/30/202213,120,000 shares $625.04 million +5.8%23.9%11.3 $47.64 9/15/202212,400,000 shares $750.08 million +2.1%22.6%10 $60.49Automatic Income (from home) (Ad)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video BEAM Short Interest - Frequently Asked Questions What is Beam Therapeutics' current short interest? Short interest is the volume of Beam Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 14,020,000 shares of BEAM short. Learn More on Beam Therapeutics' current short interest. What is a good short interest ratio for Beam Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAM shares currently have a short interest ratio of 9.0. Learn More on Beam Therapeutics's short interest ratio. Which institutional investors are shorting Beam Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Beam Therapeutics: Walleye Trading LLC, Jane Street Group LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Beam Therapeutics' short interest increasing or decreasing? Beam Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 14,020,000 shares, an increase of 6.5% from the previous total of 13,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Beam Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Beam Therapeutics: Sana Biotechnology, Inc. (20.85%), Novavax, Inc. (32.00%), ADMA Biologics, Inc. (3.82%), Ginkgo Bioworks Holdings, Inc. (20.84%), Fusion Pharmaceuticals Inc. (4.64%), Kymera Therapeutics, Inc. (16.15%), Inhibrx, Inc. (4.18%), Apogee Therapeutics, Inc. (14.00%), Recursion Pharmaceuticals, Inc. (24.98%), Vericel Co. (9.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Beam Therapeutics stock? Short selling BEAM is an investing strategy that aims to generate trading profit from Beam Therapeutics as its price is falling. BEAM shares are trading up $0.83 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Beam Therapeutics? A short squeeze for Beam Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAM, which in turn drives the price of the stock up even further. How often is Beam Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SANA Short Interest Data NVAX Short Interest Data ADMA Short Interest Data DNA Short Interest Data FUSN Short Interest Data KYMR Short Interest Data INBX Short Interest Data APGE Short Interest Data RXRX Short Interest Data VCEL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BEAM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club